Evidence map›Paper›PMID 42588560›Full record

ArticleMolecules (Basel, Switzerland)2026

Mutagenesis and Analysis for Enhancing (2

Zilong Liu, Haoran Cui, Yuxuan Jiang, Zhiwen Wang, Tao Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zilong LiuState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin 300072, China.
Haoran CuiState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin 300072, China.
Yuxuan JiangState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin 300072, China.
Zhiwen WangState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin 300072, China.
Tao ChenState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin 300072, China.ORCID 0000-0001-9588-1821

Funding

National Key Research and Development Program of China 2025YFA0922800National Natural Science Foundation of China NSFC-22278313
6 · The paper itself

Abstract

2,3-Butanediol (2,3-BD) is a versatile bulk chemical, serving as a high-boiling green solvent, a key monomer for polyesters and polyurethanes, and a crucial intermediate in the production of fine chemicals and cosmetics. Additionally, it is a key intermediate for pharmaceuticals and agrochemicals, supporting green chemistry. Microbial production of 2,3-BD offers a sustainable bioprocess but faces the challenge of high-concentration product inhibition. In an effort to improve 2,3-BD tolerance and production in

Indexed as

Butylene GlycolsCorynebacterium glutamicumMutagenesisFermentationMetabolic EngineeringMutation2,3-butylene glycolButylene Glycols2,3-butanediolARTP mutagenesisCorynebacterium glutamicumcytotoxicitymicrobial fermentationreverse engineeringtolerance

Identifiers

PMID42588560
PMCPMC13467605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.